Influence of Hepatic Steatosis (Fatty Liver) on Severity and Composition of Dyslipidemia in Type 2 Diabetes
- 1 August 2006
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (8), 1845-1850
- https://doi.org/10.2337/dc06-0455
Abstract
OBJECTIVE—The objective of this study was to examine the associations between the severity of hepatic steatosis and dyslipidemia in type 2 diabetes, including circulating apolipoprotein B100 (apoB) concentrations and lipoprotein particle size and numbers. RESEARCH DESIGN AND METHODS—Computed tomography imaging was used to assess hepatic fat content and adipose tissue distribution in 67 men and women with type 2 diabetes, withdrawn from antidiabetic medications preceding the study. Fasting serum lipoprotein number and size was determined by nuclear magnetic resonance. Insulin sensitivity was measured with a glucose clamp and a [6,6-2H2]glucose isotope infusion. RESULTS—Two-thirds of the cohort had fatty liver. Hepatic steatosis correlated with serum triglycerides (r = 0.40, P < 0.01) and lower HDL cholesterol (r = −0.31, P < 0.05). ApoB and LDL cholesterol did not, being virtually identical in those with or without steatosis. The association between serum triglycerides and hepatic steatosis was largely accounted for by greater triglyceride enrichment in VLDL particles, which were larger. Severe steatosis was also associated with 70% higher small, dense LDL concentrations. Visceral obesity did not fully explain these associations, and hepatic steatosis was better correlated with triglycerides than with hyperglycemia or hepatic insulin resistance (P > 0.05). CONCLUSIONS—The presence of hepatic steatosis in type 2 diabetes does not appear to affect apoB levels, but potentially increases atherogenesis by increasing triglycerides, reducing HDL levels, and increasing small, dense LDL.Keywords
This publication has 34 references indexed in Scilit:
- Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis StudyMetabolism, 2005
- Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic AdultsArchives of Internal Medicine, 2004
- Non‐alcoholic steatohepatitis in type 2 diabetes mellitusJournal of Gastroenterology and Hepatology, 2004
- Influence of Plasma Free Fatty Acids on Lipoprotein Synthesis and Diabetic DyslipidemiaExperimental and Clinical Endocrinology & Diabetes, 2003
- Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal MenJournal of Clinical Endocrinology & Metabolism, 2002
- Diabetic Dyslipidemia: Causes and ConsequencesJournal of Clinical Endocrinology & Metabolism, 2001
- Visceral fat and insulin resistance — causative or correlative?British Journal of Nutrition, 2000
- Fatty Infiltration of the LiverInvestigative Radiology, 1993
- Radioactive and stable isotope tracers in biomedicine Book review by R.E. SerfassJournal of the American Society for Mass Spectrometry, 1993
- Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolismDiabetes, 1977